1. Home
  2. KALV vs BLMN Comparison

KALV vs BLMN Comparison

Compare KALV & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo KalVista Pharmaceuticals Inc.

KALV

KalVista Pharmaceuticals Inc.

HOLD

Current Price

$16.12

Market Cap

551.2M

Sector

Health Care

ML Signal

HOLD

BLMN

Bloomin' Brands Inc.

HOLD

Current Price

$5.92

Market Cap

569.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
KALV
BLMN
Founded
N/A
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
551.2M
569.7M
IPO Year
N/A
2012

Fundamental Metrics

Financial Performance
Metric
KALV
BLMN
Price
$16.12
$5.92
Analyst Decision
Strong Buy
Hold
Analyst Count
5
8
Target Price
$30.00
$8.50
AVG Volume (30 Days)
1.3M
2.1M
Earning Date
03-11-2026
02-25-2026
Dividend Yield
N/A
7.54%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,426,000.00
$3,952,793,000.00
Revenue This Year
N/A
$2.22
Revenue Next Year
$204.16
$0.40
P/E Ratio
N/A
N/A
Revenue Growth
N/A
7.72
52 Week Low
$8.74
$5.86
52 Week High
$19.00
$12.91

Technical Indicators

Market Signals
Indicator
KALV
BLMN
Relative Strength Index (RSI) 54.89 34.81
Support Level $15.22 $7.30
Resistance Level $16.16 $6.86
Average True Range (ATR) 0.88 0.41
MACD -0.01 -0.19
Stochastic Oscillator 76.95 3.08

Price Performance

Historical Comparison
KALV
BLMN

About KALV KalVista Pharmaceuticals Inc.

KalVista Pharmaceuticals Inc is a pharmaceutical company developing and delivering oral therapies for individuals affected by rare diseases with unmet needs. The company applies its knowledge in the kallikrein-kinin system (KKS) and oral drug discovery to develop small-molecule protease inhibitor medicines to address the needs of patients with diseases driven by plasma kallikrein and Factor XIIa. Its FDA-approved product EKTERLY (sebetralstat) is a novel, orally delivered, small-molecule plasma kallikrein inhibitor for the treatment of acute attacks of hereditary angioedema (HAE) in adult and pediatric patients aged twelve years and older.

About BLMN Bloomin' Brands Inc.

Bloomin Brands Inc operates as a casual dining restaurant company. The company's brand includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill, and Fleming's Prime Steakhouse and Wine Bar. The company owns and operates its restaurants, and the remainder is franchised. It derives revenue mainly from the United States, but the company has a presence in Brazil and South Korea with company-owned Outbacks and Carrabba's. In addition, it also has exposure to several countries, predominantly in Asia, principally through franchising. The Company aggregates its operating segments into two reportable segments, U.S. and international. The U.S. segment includes all restaurants operating in the U.S., while restaurants operating outside the U.S. are included in the international segment.

Share on Social Networks: